“Developments in virus-like particle-based vaccines for infectious diseases and cancer”. Expert Review of Vaccines10 (11): 1569–83. (November 2011). doi:10.1586/erv.11.135. PMID22043956.
“Modeling the competition between aggregation and self-assembly during virus-like particle processing”. Biotechnology and Bioengineering107 (3): 550–60. (October 2010). doi:10.1002/bit.22821. PMID20521301.
“A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses”. Vaccine20 (25–26): 3104–12. (August 2002). doi:10.1016/S0264-410X(02)00266-9. PMID12163261.
“Developments in virus-like particle-based vaccines for infectious diseases and cancer”. Expert Review of Vaccines10 (11): 1569–83. (November 2011). doi:10.1586/erv.11.135. PMID22043956.
“Modeling the competition between aggregation and self-assembly during virus-like particle processing”. Biotechnology and Bioengineering107 (3): 550–60. (October 2010). doi:10.1002/bit.22821. PMID20521301.
“A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses”. Vaccine20 (25–26): 3104–12. (August 2002). doi:10.1016/S0264-410X(02)00266-9. PMID12163261.